Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities | Nefrología
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities | Nefrología
An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients - ScienceDirect
Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities - ScienceDirect
Full article: The use of everolimus in renal-transplant patients
Recommendations of everolimus use in liver transplant | Gastroenterología y Hepatología (English Edition)
De Novo Therapy with Everolimus and Low-Dose Calcineurin Inhibitors in Kidney Transplantation | Semantic Scholar
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities - ScienceDirect
Frontiers | Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
Everolimus dose and trough blood levels, and laboratory values for... | Download Scientific Diagram
Everolimus Dosage Guide + Max Dose, Adjustments - Drugs.com
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial - The Lancet
Everolimus with Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplant Recipients: Efficacy and Safety Outcomes from the TRANSFORM Study - ATC Abstracts
Everolimus with Reduced-Dose Calcineurin Inhibitor versus Mycophenolate with Standard-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Renal Function Results from the TRANSFORM Study - ATC Abstracts
Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study - American Journal of Transplantation
Study design. Steroid dose will be at least 5 mg prednisolone or... | Download Scientific Diagram
Article: Conversion from tacrolimus to everolimus with complete and early glucocorticoid withdrawal after kidney transplantation: a randomised trial (full text) - January 2018 - NJM
Enhanced Humoral Immune Response After COVID-19 Vaccination... : Transplantation
IJMS | Free Full-Text | Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
PDF) Conversion to everolimus in maintenance patients - Current clinical strategies
Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions - ScienceDirect
Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trial - American Journal of Transplantation
Transplantology | Free Full-Text | Dyslipidemia in Renal Transplant Recipients
